David has made over 1 trades of the Apollo Endosurgery Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 18,742 units of APEN stock worth 128,758$ on 19 May 2021.
The largest trade he's ever made was selling 18,742 units of Apollo Endosurgery Inc stock on 19 May 2021 worth over 128,758$. On average, David trades about 2,677 units every 0 days since 2017.
You can see the complete history of Mr. Pacitti stock trades at the bottom of the page.
David C. Pacitti serves as Independent Director of the Company. Since November 2017, Mr. Pacitti has served as a member of our Board. Since 2015, Mr. Pacitti has served as the President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers where he is responsible for leading the marketing, sales, service, and support functions in North America and Latin America, across the entire Healthineers portfolio, including medical imaging, laboratory diagnostics, therapy solutions, and services. From February 2006 to October 2015, Mr. Pacitti was with Abbott Vascular, a division of Abbott Laboratories, in a variety of commercial leadership roles. He serves as a member of the Board of Directors of the Advanced Medical Technology Association (AvaMed), the University City Science Center in Philadelphia, PA, the National Electrical Manufacturers Association (NEMA), and the Siemens Foundation. He is also a member of the CEO Council for Growth at the Chamber of Commerce for Greater Philadelphia, as well as the Children's Hospital of Philadelphia Corporate Council, the GAVS Customer Advisory Board, the Medical University of South Carolina (MUSC) President’s Advisory Council and the NextGen Advisory Board for the University of Missouri. Mr. Pacitti received a B.A. in Economics from Villanova University.
David Pacitti is 54, he's been the Independent Director of Apollo Endosurgery Inc since 2017. There are 13 older and 5 younger executives at Apollo Endosurgery Inc. The oldest executive at Apollo Endosurgery Inc is Dr. Christopher J. Gostout, 70, who is the Co-Founder & Chief Medical Officer.
David's mailing address filed with the SEC is 1120 S Capital of Texas Hwy #300, Austin, TX 78746, USA.
Over the last 12 years, insiders at Apollo Endosurgery Inc have traded over 3,882,241$ worth of Apollo Endosurgery Inc stock and bought 10,717,094 units worth 45,588,363$ . The most active insiders traders include Holdings A/S Novo、Neil Gagnon、R Kent Jr Mc Gaughy. On average, Apollo Endosurgery Inc executives and independent directors trade stock every 41 days with the average trade being worth of 2,726,880$. The most recent stock trade was executed by Jeffrey G. Black on 25 February 2022, trading 40,000 units of APEN stock currently worth 229,200$.
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Apollo Endosurgery Inc executives and other stock owners filed with the SEC include: